WORLDLAB - EUROMEDLAB ROMA 2023
Thank you for your interest in the ELF Test!
The Enhanced Liver Fibrosis (ELF™) Test can be used diagnostically for fibrosis staging or prognostically to indicate the risk of a patient‘s progression to cirrhosis and liver-related clinical events (LREs).1
In the U.S. the ELF Test is not for use in the diagnosis of NASH or for the staging of fibrosis. The ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.